Hematologic and biochemical monitoring throughout the trials revealed no concerning patterns in blood counts, liver function tests, kidney function markers, or other laboratory parameters
Some patients experiment with twice-weekly dosing, but published data doesn't support additional benefit
Updated reports will be posted here once finalized
But that doesnt mean other high-level physicians and biohackers have ignored its positive yet powerful effects on body recomposition
Timmermans notes that the patent for BPC-157 expired long ago, which means that no company presently has a clear profit motive to spend millions to fund human studies
Telogen Effluvium A temporary but often alarming condition where a significant percentage of hair follicles enter the resting (telogen) phase simultaneously, leading to diffuse shedding 2-3 months after a triggering event